Evaluation of the Effectiveness of Oral Ozonized Oil Supplementation in Elite Athletes
Evaluation of the Effects of Ozonated Oil Administration on Athletic Performance and Injury Prevention in Elite Athletes.
2 other identifiers
interventional
33
1 country
2
Brief Summary
Ozonized oil has anti-inflammatory and antioxidant properties, but its effects on athletic performance remain unclear. This study evaluated whether daily ozonized oil supplementation, combined with training, influences aerobic capacity, anaerobic power, maximal strength, and muscular endurance in elite rugby players over six months
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2024
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 17, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 18, 2025
CompletedFirst Submitted
Initial submission to the registry
April 16, 2026
CompletedFirst Posted
Study publicly available on registry
September 3, 2026
CompletedSeptember 3, 2026
April 1, 2026
7 months
April 16, 2026
August 31, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
The primary objective was to investigate the effects of ozonated oil administration on athletic performance and injury prevention in a group of 21 rugby athletes, divided into two groups: Experimental group (n=13) vs Control group (n=8)
Bruce test: which measures a subject's maximal oxygen consumption (VO2max). VO2max represents the maximum aerobic power, that is, the maximum amount of energy that can be synthesized by the aerobic mechanism in a unit of time.
1 year
Secondary Outcomes (2)
The primary objective was to investigate the effects of ozonated oil administration on athletic performance and injury prevention in a group of 21 rugby athletes, divided into two groups: Experimental group (n=13) vs Control group (n=8)
1 year
The primary objective was to investigate the effects of ozonated oil administration on athletic performance and injury prevention in a group of 21 rugby athletes, divided into two groups: Experimental group (n=13) vs Control group (n=8)
1 year
Study Arms (2)
Intervention group (IG): received daily ozonized oil supplementation
EXPERIMENTALThe IG received the supplement of ozonized oil capsules (O3ZONE Sport ®). Dosage was standardized and adjusted according to body: * ≥100 kg: 6 capsules/day (3 morning, 3 evening) * \<100 kg: 4 capsules/day (2 morning, 2 evening) Adherence to the protocol was monitored weekly through self-report and supervision by team medical staff. Both groups followed identical training protocols; the IG additionally received daily ozonized oil. Performance was assessed at baseline, 3 months, and 6 months using the Bronco test (field endurance), Bruce and Léger tests (estimated VO2max), the Running-Based Anaerobic Sprint Test (RAST), and tests of quadriceps and bench-press 1-repetition maximum (1RM) and endurance at 50% 1RM. Outcomes were expressed as percentage change from baseline
• Control group (CG): n = 15, which continued standard training without supplementation
NO INTERVENTIONInterventions
, the present study aimed to investigate the potential effects of daily oral supplementation with ozonized oil (O3ZONE Sport®) (produced for O3 ZONE LIMITED, Acquaviva, RSM) on physical performance outcomes - aerobic capacity, maximal strength, muscular endurance, and functional fitness - in elite rugby players over a six-month training period.
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Stadio del Rugby
Avezzano, AQ, 67051, Italy
University of Genova
Genova, Genova, 16132, Italy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full Professor of Hygiene and Preventive Medicine School of Medicine, University of Genoa, Italy Director PhD School in Health Sciences and Cancer Prevention
Study Record Dates
First Submitted
April 16, 2026
First Posted
September 3, 2026
Study Start
September 9, 2024
Primary Completion
April 17, 2025
Study Completion
April 18, 2025
Last Updated
September 3, 2026
Record last verified: 2026-04